Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    March 2017
  1. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed     Text format    


  2. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed     Text format    


    February 2017
  3. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Text format     Abstract available


    January 2017
  4. WEISSBERGER GH, Melrose RJ, Narvaez TA, Harwood D, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 31. pii: S1064-7481(17)30034.
    PubMed     Text format     Abstract available


  5. SMITH GS
    Molecular Imaging of the Nicotinic Cholinergic Receptor in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 5. pii: S1064-7481(17)30001.
    PubMed     Text format    


  6. SULTZER DL, Melrose RJ, Riskin-Jones H, Narvaez TA, et al
    Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30305.
    PubMed     Text format     Abstract available


  7. GATCHEL JR, Donovan NJ, Locascio JJ, Becker JA, et al
    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30348.
    PubMed     Text format     Abstract available


    November 2016
  8. KERNER NA, Roose SP, Pelton GH, Ciarleglio A, et al
    Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.
    Am J Geriatr Psychiatry. 2016 Nov 17. pii: S1064-7481(16)30303.
    PubMed     Text format     Abstract available


  9. REGAN B, Wells Y, Farrow M, O'Halloran P, et al
    MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Nov 16. pii: S1064-7481(16)30302.
    PubMed     Text format     Abstract available


    October 2016
  10. LIN A, Brook J, Grill JD, Teng E, et al
    Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Oct 13. pii: S1064-7481(16)30273.
    PubMed     Text format     Abstract available


    September 2016
  11. STEFFENS EB, Steffens DC
    Getting on Message: Preventing Alzheimer Disease Through Diet and Exercise.
    Am J Geriatr Psychiatry. 2016;24:738-9.
    PubMed     Text format    


    August 2016
  12. ANTONSDOTTIR IM, Makino KM, Porsteinsson AP
    Dazed and Confused: Medical Cannabis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Aug 31. pii: S1064-7481(16)30222.
    PubMed     Text format    


  13. PALMER BW
    Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development.
    Am J Geriatr Psychiatry. 2016 Aug 4. pii: S1064-7481(16)30178.
    PubMed     Text format    


  14. COHEN AD, Aizenstein HJ
    Brain Amyloidosis and Triglycerides: Preventing Alzheimer Disease Pathology by Treating Vascular Disease?
    Am J Geriatr Psychiatry. 2016;24:613-4.
    PubMed     Text format    


    July 2016
  15. MENDES-SILVA AP, Pereira KS, Tolentino-Araujo GT, Nicolau ES, et al
    Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies.
    Am J Geriatr Psychiatry. 2016 Jul 25. pii: S1064-7481(16)30185.
    PubMed     Text format     Abstract available


  16. ROY S, Ficarro S, Duberstein P, Chapman BP, et al
    Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Jul 4. pii: S1064-7481(16)30165.
    PubMed     Text format     Abstract available


    May 2016
  17. POMARA N, Bruno D
    Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 May 6. pii: S1064-7481(16)30108.
    PubMed     Text format    


    April 2016
  18. BABULAL GM, Ghoshal N, Head D, Vernon EK, et al
    Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
    Am J Geriatr Psychiatry. 2016 Apr 19. pii: S1064-7481(16)30082.
    PubMed     Text format     Abstract available


  19. MAUST DT, Bonar EE, Ilgen MA, Blow FC, et al
    Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States.
    Am J Geriatr Psychiatry. 2016 Apr 11. pii: S1064-7481(16)30061.
    PubMed     Text format     Abstract available


  20. LOEWENSTEIN DA, Curiel RE, Greig MT, Bauer RM, et al
    A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.
    Am J Geriatr Psychiatry. 2016 Apr 4. pii: S1064-7481(16)30004.
    PubMed     Text format     Abstract available


    March 2016
  21. PARK JH, Myung W, Choi J, Kim S, et al
    Extrapyramidal Signs and Cognitive Subdomains in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Mar 15. pii: S1064-7481(16)00217.
    PubMed     Text format     Abstract available


    February 2016
  22. BRUCE ML
    Advances in Methodology in Geriatric Mental Health: Application to Studies of Alzheimer Disease and Related Disorders.
    Am J Geriatr Psychiatry. 2016 Feb 2. pii: S1064-7481(16)00152.
    PubMed     Text format     Abstract available


  23. CHOI HJ, Seo EH, Yi D, Sohn BK, et al
    Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Am J Geriatr Psychiatry. 2016;24:144-53.
    PubMed     Text format     Abstract available


    November 2015
  24. SMALL GW, Greenfield S
    Current and Future Treatments for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015;23:1101-5.
    PubMed     Text format    


    July 2015
  25. STROHLE A, Schmidt DK, Schultz F, Fricke N, et al
    Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-analysis of Effects on Cognition in Randomized Controlled Trials.
    Am J Geriatr Psychiatry. 2015 Jul 21. pii: S1064-7481(15)00213.
    PubMed     Text format     Abstract available


  26. HONGISTO K, Vaatainen S, Martikainen J, Hallikainen I, et al
    Self-Rated and Caregiver-Rated Quality of Life in Alzheimer Disease with a Focus on Evolving Patient Ability to Respond to Questionnaires: 5-Year Prospective ALSOVA Cohort Study.
    Am J Geriatr Psychiatry. 2015 Jul 17. pii: S1064-7481(15)00206.
    PubMed     Text format     Abstract available


    June 2015
  27. MAK E, Li S, Williams GB, Watson R, et al
    Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 Jun 25. pii: S1064-7481(15)00192.
    PubMed     Text format     Abstract available


  28. WILLIAMS MA, McKay GJ, Carson R, Craig D, et al
    Age-Related Macular Degeneration-Associated Genes in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 Jun 24. pii: S1064-7481(15)00191.
    PubMed     Text format     Abstract available


    May 2015
  29. WROOLIE TE, Kenna HA, Williams KE, Rasgon NL, et al
    Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 21. pii: S1064-7481(15)00169.
    PubMed     Text format     Abstract available


  30. WEINTRAUB D, Drye LT, Porsteinsson AP, Rosenberg PB, et al
    Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 19. pii: S1064-7481(15)00164.
    PubMed     Text format     Abstract available


  31. CINES S, Farrell M, Steffener J, Sullo L, et al
    Examining the Pathways between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 19. pii: S1064-7481(15)00163.
    PubMed     Text format     Abstract available


    March 2015
  32. SACUIU S, Insel PS, Mueller S, Tosun D, et al
    Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.
    Am J Geriatr Psychiatry. 2015 Mar 30. pii: S1064-7481(15)00136.
    PubMed     Text format     Abstract available


    January 2015
  33. WATSON R, Colloby SJ, Blamire AM, O'Brien JT, et al
    Assessment of regional gray matter loss in dementia with Lewy bodies: a surface-based MRI analysis.
    Am J Geriatr Psychiatry. 2015;23:38-46.
    PubMed     Text format     Abstract available


    October 2014
  34. YI D, Lee DY, Sohn BK, Choe YM, et al
    Beta-amyloid associated differential effects of APOE epsilon4 on brain metabolism in cognitively normal elderly.
    Am J Geriatr Psychiatry. 2014;22:961-70.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: